Hong Fang Song - Dec 16, 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Hong Fang Song
Stock symbol
CGON
Transactions as of
Dec 16, 2024
Transactions value $
-$19,600,000
Form type
4
Date filed
12/17/2024, 06:03 PM
Previous filing
Oct 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGON Common Stock Sale -$19.6M -700K -18.9% $28.00 3M Dec 16, 2024 By Charming Jade Limited F1, F2, F3
holding CGON Common Stock 587K Dec 16, 2024 By Unique Diamond Investments Limited F3, F4
holding CGON Common Stock 614K Dec 16, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were offered and sold by Charming Jade Limited in connection with the Issuer's public offering pursuant to the Registration Statement on Form S-1 (File No. 333-283725) that closed on December 16, 2024.
F2 Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.
F3 Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.
F4 Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.